Biohaven (BHVN) Change in Acquisitions & Divestments (2023 - 2026)
Biohaven (BHVN) posted Change in Acquisitions & Divestments of $35.0 million for Q1 2026, down 53.33% sequentially from $75.0 million in Q4 2025, and down 83.33% YoY from $210.0 million in Q1 2025.
Analysis
Biohaven (BHVN) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Biohaven has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $35.0 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 83.33% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $395.0 million (down 1.74% YoY) and the FY2025 annual result came in at $570.0 million, up 13.01% from the prior year.
- Change in Acquisitions & Divestments slipped to $35.0 million in Q1 2026 per BHVN's latest filing, from $75.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $210.0 million in Q1 2025 and troughed at $2.5 million in Q2 2023.
- A 4-year average of $99.1 million and a median of $94.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments jumped 3149.16% in 2024, then slumped 83.33% in 2026.
- Over 4 years, Change in Acquisitions & Divestments stood at $107.9 million in 2023, then surged by 78.02% to $192.0 million in 2024, then sank by 60.94% to $75.0 million in 2025, then sank by 53.33% to $35.0 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $35.0 million, $75.0 million, and $165.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Biohaven | 2.37 Bn | 2.10 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 165.00 Mn |
| Jun 30, 2025 | 120.00 Mn |
| Mar 31, 2025 | 210.00 Mn |
| Dec 31, 2024 | 192.00 Mn |
| Mar 31, 2024 | 81.16 Mn |
| Dec 31, 2023 | 107.86 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 27.00 Mn |